GB9400882D0 - Esters with dicarbonic acids having antitumour properties - Google Patents
Esters with dicarbonic acids having antitumour propertiesInfo
- Publication number
- GB9400882D0 GB9400882D0 GB9400882A GB9400882A GB9400882D0 GB 9400882 D0 GB9400882 D0 GB 9400882D0 GB 9400882 A GB9400882 A GB 9400882A GB 9400882 A GB9400882 A GB 9400882A GB 9400882 D0 GB9400882 D0 GB 9400882D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- esters
- dicarbonic acids
- antitumour properties
- antitumour
- properties
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH3159/91A CH681891A5 (en) | 1992-10-09 | 1992-10-09 | |
DE4319492A DE4319492A1 (en) | 1992-10-09 | 1993-06-11 | dicarboxylic |
GB9400882A GB2285805A (en) | 1992-10-09 | 1994-01-18 | Esters |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH3159/91A CH681891A5 (en) | 1992-10-09 | 1992-10-09 | |
GB9400882A GB2285805A (en) | 1992-10-09 | 1994-01-18 | Esters |
Publications (2)
Publication Number | Publication Date |
---|---|
GB9400882D0 true GB9400882D0 (en) | 1994-03-16 |
GB2285805A GB2285805A (en) | 1995-07-26 |
Family
ID=25692340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9400882A Withdrawn GB2285805A (en) | 1992-10-09 | 1994-01-18 | Esters |
Country Status (3)
Country | Link |
---|---|
CH (1) | CH681891A5 (en) |
DE (1) | DE4319492A1 (en) |
GB (1) | GB2285805A (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH681891A5 (en) * | 1992-10-09 | 1993-06-15 | Marigen Sa | |
US5593691A (en) * | 1993-06-03 | 1997-01-14 | Marigen S.A. | Biotenside solvents for pharmaceuticals and cosmetics |
JP2001509137A (en) * | 1996-11-12 | 2001-07-10 | タマーキン ファーマシューティカル イノベイション リミテッド | How to treat skin diseases |
FI974648A (en) | 1997-09-09 | 1999-05-06 | Raisio Benecol Oy | Hydroxy acid, lactic acid and hydroxyalkanoate esters and their uses |
US6394230B1 (en) * | 1997-12-16 | 2002-05-28 | Cognis Corporation | Sterol esters as food additives |
US5892068A (en) * | 1998-08-25 | 1999-04-06 | Mcneil-Ppc, Inc. | Preparation of sterol and stanol-esters |
FR2829762B1 (en) * | 2001-09-17 | 2004-02-13 | Fabre Pierre Dermo Cosmetique | BIOPRECURSORS FOR A PERCUTANEOUS APPLICATION |
DK2334378T3 (en) | 2008-08-19 | 2014-07-07 | Xenoport Inc | Methyl hydrogen fumarate prodrugs, pharmaceutical compositions thereof and methods of use |
US10945984B2 (en) | 2012-08-22 | 2021-03-16 | Arbor Pharmaceuticals, Llc | Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects |
AU2013305684B2 (en) | 2012-08-22 | 2016-11-24 | Xenoport, Inc. | Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof |
HUE040044T2 (en) | 2013-03-14 | 2019-02-28 | Alkermes Pharma Ireland Ltd | Prodrugs of fumarates and their use in treating various deseases |
US8669281B1 (en) | 2013-03-14 | 2014-03-11 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
WO2014160633A1 (en) | 2013-03-24 | 2014-10-02 | Xenoport, Inc. | Pharmaceutical compositions of dimethyl fumarate |
US9302977B2 (en) | 2013-06-07 | 2016-04-05 | Xenoport, Inc. | Method of making monomethyl fumarate |
WO2014205392A1 (en) | 2013-06-21 | 2014-12-24 | Xenoport, Inc. | Cocrystals of dimethyl fumarate |
DE102013215580A1 (en) | 2013-08-07 | 2015-02-12 | Orgentec Diagnostika Gmbh | 25-OH Vitamin D derivatives for the determination of vitamin D metabolites |
TW201516020A (en) | 2013-09-06 | 2015-05-01 | Xenoport Inc | Crystalline forms of (N,N-diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use |
US9604922B2 (en) | 2014-02-24 | 2017-03-28 | Alkermes Pharma Ireland Limited | Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases |
US9999672B2 (en) | 2014-03-24 | 2018-06-19 | Xenoport, Inc. | Pharmaceutical compositions of fumaric acid esters |
CN104434927A (en) * | 2014-12-16 | 2015-03-25 | 吉林农业大学 | Application of bicyclopentanoperhydrophenanthrene malonate B in preparing hypotensive drugs |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB760346A (en) * | 1952-12-18 | 1956-10-31 | Roche Products Ltd | Novel esters of bixins and norbixins and process for the manufacture thereof |
DE3672270D1 (en) * | 1985-03-06 | 1990-08-02 | Yoshikawa Oil & Fat | METHOD FOR PRODUCING FATTY ACID ESTERS. |
US5198432A (en) * | 1988-01-29 | 1993-03-30 | Center For Innovative Technology | Method of preventing chlorohydrocarbon toxicity using sterol derivatives |
CH681891A5 (en) * | 1992-10-09 | 1993-06-15 | Marigen Sa |
-
1992
- 1992-10-09 CH CH3159/91A patent/CH681891A5/de not_active IP Right Cessation
-
1993
- 1993-06-11 DE DE4319492A patent/DE4319492A1/en not_active Withdrawn
-
1994
- 1994-01-18 GB GB9400882A patent/GB2285805A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2285805A (en) | 1995-07-26 |
CH681891A5 (en) | 1993-06-15 |
DE4319492A1 (en) | 1994-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9400882D0 (en) | Esters with dicarbonic acids having antitumour properties | |
AP9200416A0 (en) | Imidazolyl-alkenoic acids | |
HU9302843D0 (en) | Quinolone carboxylic acids | |
GB9325558D0 (en) | Percaboxylic acids | |
EP0442448A3 (en) | Heterocyclic carboxylic acids and esters | |
ZA921840B (en) | Triazinyl-substituted acrylic esters | |
ZA914555B (en) | 2-methoximinocarboxylic esters | |
ZA938988B (en) | Substituted benzoic acids | |
AU5164693A (en) | 17 beta -aryl ester carboxylates of 4-aza-5alpha-androstane-3-ones | |
AU1432092A (en) | Quinoxaline phosphono-amino acids | |
GB8711524D0 (en) | Carboxylic acids | |
EP0531821A3 (en) | 1-alkoxyhexatriene-2-carboxylic acid esters | |
GB9213420D0 (en) | Aromatic carboxylic acids | |
GB9303500D0 (en) | Carboxylic acid esters fo hydroxyphenylalkanols as stabilisers | |
EP0539043A3 (en) | Novel esters | |
ZA918719B (en) | Ester inhibitors | |
EP0557035A3 (en) | An ester cleavage process for use with beta-lactams | |
IL105888A0 (en) | Novel thiosemicarbazonic acid esters | |
GB9304619D0 (en) | Esters | |
GB9218762D0 (en) | Esters | |
EP0584556A3 (en) | Chlorendic anhydride half ester | |
GB9216026D0 (en) | Esterification process | |
IE901193L (en) | 5-alkylquinolone carboxylic acids | |
GB9221636D0 (en) | Esters | |
GB9221512D0 (en) | Phenylpyrazine esters |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |